Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Schering-Plough Corp. (NYSE:SGP)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Reports
Recent Events
Aug 28Dividend payment of $0.16
Location
2000 Galloping Hill Road
Kenilworth, NJ 07033
Phone: (908) 298-4000
Fax: (908) 298-7082
Employees (last reported count): 28,100
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 14%
·Over the last 6 months:
 · 2 insider sells; 6,000  shares
·Institutional: 67% (78% of float)
(2,300 institutions)
·Net Inst. Selling: 2.09M shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Schering-Plough Corporation, a worldwide research-based pharmaceutical company, and its subsidiaries are engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. Although discovery and development efforts target the field of human health, application in the field of animal health can result from these efforts. The Company operates primarily in the prescription pharmaceutical marketplace. However, where appropriate, the Company has sought regulatory approval to switch prescription products to over-the-counter (OTC) status as a means of extending a product's life cycle. In this way, the OTC marketplace is yet another means of maximizing the return on investments in discovery and development.
More from Market Guide: Expanded Business Description

Financial Summary
SGP is engaged in the discovery, development, manufacturing and marketing of pharmaceutical and health care products worldwide, including prescription drugs, animal health, over-the-counter, foot care and sun care products. For the six months ended 6/30/01, revenues fell 1% to $4.95 billion. Net income fell 5% to $1.2 billion. Results reflect foreign exchange rate fluctuations, lower sales of LOTRISONE and increased costs related to manufacturing issues.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Richard Kogan, 59
Chairman, CEO, Director
$9.9M$11.6M
Jack Wyszomierski, 45
Exec. VP, CFO
2.5M6.9M
Joseph Connors, 52
Exec. VP, Gen. Counsel
2.6M4.9M
John Ryan, 60
Sr. VP/Director of HR
--  --  
Geraldine Foster, 57
Sr. VP of Investor Relations and Corp. Communications
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:SGPAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$33.86 
Recent Price$38.13 
52-Week High
on 20-Dec-2000
$60.00 
Beta0.82 
Daily Volume (3-month avg)5.15M
Daily Volume (10-day avg)3.46M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-4.8%
52-Week Change
relative to S&P500
+27.7%
Share-Related Items
Market Capitalization$55.8B
Shares Outstanding1.46B
Float1.26B
Dividends & Splits
Annual Dividend (indicated)$0.64 
Dividend Yield1.68%
Last Split: 2 for 1 on 3-Dec-1998
Per-Share Data
Book Value (mrq)$4.66 
Earnings (ttm)$1.60 
Earnings (mrq)$0.43 
Sales (ttm)$6.62 
Cash (mrq)$1.75 
Valuation Ratios
Price/Book (mrq)8.18 
Price/Earnings (ttm)23.80 
Price/Sales (ttm)5.76 
Income Statements
Sales (ttm)$9.75B
EBITDA (ttm)$3.39B
Income available to common (ttm)$2.36B
Profitability
Profit Margin (ttm)24.2%
Operating Margin (ttm)31.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)21.99%
Return on Equity (ttm)38.31%
Financial Strength
Current Ratio (mrq)1.73 
Debt/Equity (mrq)0.13 
Total Cash (mrq)$2.56B
Short Interest
As of 8-Aug-2001
Shares Short8.67M
Percent of Float0.7%
Shares Short
(Prior Month)
9.20M
Short Ratio1.84 
Daily Volume4.72M
See Profile Help for a description of each item above;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.